Plasma NGS detected pathogens from deep infection sites in subjects with negative blood cultures

Escherichia coli 36
Staphylococcus aureus 16
Enterococcus faecium 8
Klebsiella species (K. pneumoniae or K. oxytoca) 6
Pseudomonas aeruginosa 6
Streptococcus mitis group 5
Enterobacter species (E. cloacae or E. aerogenes) 4
Enterococcus faecalis 3
Streptococcus pneumoniae 3
Streptococcus dysgalactiae 2
Bacillus cereus 2
Number of true positives
Coagulase Background: Blood cultures are routinely obtained during the diagnostic evaluation for a number of infectious conditions such as sepsis, febrile neutropenia, and pneumonia. Despite its ubiquitous use, blood cultures have poor sensitivity due to a number of factors including previous antibiotic therapy or the presence of poorly-growing fastidious organisms. There is a need for more comprehensive diagnostic tests that can overcome these limitations to aid in guiding therapy.
Methods:
We developed a plasma next-generation sequencing (NGS) assay capable of detecting over 5,000 bacteria, viruses and eukaryotic pathogens. To evaluate this assay in bacteremia, patients with multi-set positive and negative blood cultures were identified.
We used our assay to analyze residual plasma samples that were obtained on the same day as the blood cultures. DNA was extracted from plasma and NGS performed. After filtering human reads, remaining reads were aligned to a pathogen sequence database.
Relative abundance of each individual microorganism was calculated and pathogens estimated to be present with high statistical significance were identified.
Results:
In comparing this novel NGS assay to blood culture and all other microbiologic data obtained from the patient, Positive Agreement was 82.4% (112/136) and Negative Agreement was 79.1% (106/134) with an Overall Agreement of 80.7%. When comparing directly to blood culture, there was agreement in culture-positive specimens in 100 of 125 specimens (80.0%). For blood culture-negative specimens, NGS did not detect a pathogen in 107 of 145 specimens (73.8%). Of the 38 false positives detected by the NGS assay as compared with blood culture, 10 were found to be true positives when compared with microbiologic data from the patient. These included detection of pathogens by plasma NGS that were found in endotracheal cultures, nasopharyngeal PCR, peritoneal cultures, or recently positive blood cultures.
Conclusion:
We present data that show high concordance between a novel NGS assay and blood culture in patients with and without bacteremia. In addition, the assay was able to identify pathogens in plasma corresponding to pathogens identified from culture of other body sites. These results highlight the increased sensitivity in culture-negative infections and the broad nature of this assay.
-Plasma NGS can detect a broad array of pathogens -There is high concordance between a novel NGS plasma assay and blood culture in patients with and without bacteremia -26.3% of plasma NGS-positive/blood culture-negative samples were confirmed using additional microbiologic data 
